Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma

Table 1

Clinical criteria for adjuvant therapy or investigations and neoadjuvant therapeutic investigations.

Adjuvant Therapy	Neoadjuvant Therapy
Resected primary tumor	T1-4 NX/1 M0
and	or
pT2-3 N0 M0 (grades 2-4)	T1-4 NX/1 M1
or	or
pT4 N0 M0	Borderline resectable mass
or	or
pTany N1 M0	Facilitating nephron-sparing surgery
	or
	Downstaging IVC thrombus